AGENDA DOWNLOAD:
10th Annual Managed Markets and Account Management Strategies Conference

September 12-13, 2018 | San Antonio, TX

Grand Hyatt San Antonio

Please Complete the Form to Download the Agenda

ABOUT THE CONFERENCE

As health policy within the United States continues to evolve with a new administration proposing new policies regarding current pharmaceutical product spending, executives responsible for managed market strategic accounts face an uncertain future for the coverage and reimbursement of vital health products and look to ensure continued funding for life-altering treatments from both public and private payers. Managed care executives from the manufacturing, payer, PBM and IDN organizations will offer great insight to prior authorization, co-pay accumulators, and exclusion lists all of which have great impact on the bottom line of pharmaceutical corporations. Following payer discussions, experts will lead multiple boardroom discussion groups delving into topics ranging from change proposals to Medicare Part B and D, value-based contracting through to product review meeting optimization. Interactive discussions will enable all stakeholders from the pharmaceutical and payer communities as well as pharmacy benefit managers the opportunity for open debate and discussion to ensure mutually beneficial relationships between patients and caregivers.

WHO SHOULD ATTEND:

Executives from the pharmaceutical and biotechnology industry that will find this meeting of greatest application are those involved in the strategic development and tactical execution of managed markets and account managed strategies creating greater formulary coverage and patient access for products while ensuring positive relationships with managed care organization executives. Tracked presentations and breakout discussion groups will provide an unrivaled opportunity for executive led discussion and deep analysis of the challenges faced by managed market executives. Robust roundtable discussions featuring a range of healthcare thought leaders including commercial payer and PBM organizations will ensure a comprehensive delivery of content for this dynamic field. Participants most applicable for this meeting include Vice Presidents, Directors, Managers and Heads of:

  • Managed Markets
  • Managed Care
  • National Accounts
  • Regional Accounts
  • Payer Relations

ABOUT THE CONFERENCE

As health policy within the United States continues to evolve with a new administration proposing new policies regarding current pharmaceutical product spending, executives responsible for managed market strategic accounts face an uncertain future for the coverage and reimbursement of vital health products and look to ensure continued funding for life-altering treatments from both public and private payers. Managed care executives from the manufacturing, payer, PBM and IDN organizations will offer great insight to prior authorization, co-pay accumulators, and exclusion lists all of which have great impact on the bottom line of pharmaceutical corporations. Following payer discussions, experts will lead multiple boardroom discussion groups delving into topics ranging from change proposals to Medicare Part B and D, value-based contracting through to product review meeting optimization. Interactive discussions will enable all stakeholders from the pharmaceutical and payer communities as well as pharmacy benefit managers the opportunity for open debate and discussion to ensure mutually beneficial relationships between patients and caregivers.

WE GUARANTEE 100% PRIVACY, YOUR INFORMATION WILL NOT BE SHARED

Share This